University of California San Francisco
Give to UCSF
Gastrointestinal cancer surgeons at the UCSF performed the health system’s 15,000th robotically assisted minimally invasive surgery, making it the first University of California health center to reach this milestone.
Researchers have found links between lung microbial communities and mortality risk in pediatric bone marrow transplant patients. Metagenomic sequencing revealed distinct patient clusters and unexpected pathogens, highlighting the need for precise diagnostics and therapeutics. Antibiotic treatment was associated with bacterial depletion and enriched viral and fungal populations.
Energy expended for hospital and clinic electricity, climate control and ventilation is by far the biggest source of greenhouse gas emissions in radiotherapy, a treatment used in more than half of cancer cases.
UCSF will lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group, with the help of a $12.45 million grant from the National Cancer Institute (NCI).
Innovations in perinatal care, gender affirming-care and improving pregnancy outcomes for women with fibroids are among the topics UCSF clinicians will discuss at the American College of Obstetricians
The Healthcare Equality Index recognizes health care facilities for their dedication to inclusive policies and care for LGBTQ+ patients, visitors and employees.
Eating more fruits, vegetables, nuts and olive oil could significantly reduce the chances of prostate cancer progression.
Faculty members Chase Anderson, MD, and Brittany Bryant, LCSW, help us understand what microaggressions are, what they look like, and what they mean for your mental health – and practical skills to deal with them, whether they’re directed at you or not.
Group homes with a designated family doctor are a great solution for adults with intellectual and developmental disabilities (IDD).
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
UCSF scientists have been awarded more than $30 million to develop “tissue GPS,” a new system using engineered T cells to guide therapies directly to their targets in the brain to treat neurological diseases like cancer, multiple sclerosis and Alzheimer’s.
Professor emeritus Cindy Chang, MD, has had an impressive career, from being the first female chief medical officer for the U.S Olympic team, to establishing a sports medicine fellowship at UCSF.
Researchers recently identified a universal, essential biomarker for the childhood cancer neuroblastoma – and the biomarker could be a potential new target for treatment. Neuroblastoma accounts for